Prohibited List - SUBSTANCES AND METHODS PROHIBITED IN-COMPETITION

SUBSTANCES AND METHODS PROHIBITED IN-COMPETITION

In addition to the categories S0 to S5 and M1 to M3 defined above, the following categories are prohibited In-Competition:

PROHIBITED SUBSTANCES

S6. STIMULANTS

PROHIBITED IN-COMPETITION

All prohibited substances in this class are Specified Substances except those in S6.A, which are non-Specified Substances.

Substances of Abuse in this section: cocaine and methylenedioxymethamphetamine (MDMA / “ecstasy”)

All stimulants, including all optical isomers, e.g. d- and l- where relevant, are prohibited.

Stimulants include:

S6.A: Non-Specified Stimulants:

• Adrafinil
• Amfepramone
• Amfetamine
• Amfetaminil
• Amiphenazole
• Benfluorex
• Benzylpiperazine
• Bromantan
• Clobenzorex
• Cocaine
• Cropropamide
• Crotetamide
• Fencamine
• Fenetylline
• Fenfluramine
• Fenproporex
• Fladrafinil (2-[Bis(4-fluorophenyl) methylsulfinyl]-N-hydroxyacetamide)
• Flmodafinil (2-[Bis(4-fluorophenyl)methylsulfinyl]acetamide)
• Fonturacetam [4-phenylpiracetam (carphedon)]
• Furfenorex
• Hydrafinil (fluorenol)
• Lisdexamfetamine
• Mefenorex
• Mephentermine
• Mesocarb
• Metamfetamine(d-)
• p-methylamfetamine
• Modafinil
• Norfenfluramine
• Phendimetrazine
• Phentermine
• Prenylamine
• Prolintane

A stimulant not expressly listed in this section is a Specified Substance.

S6.B: Specified Stimulants.

Including, but not limited to:

• 2-phenylpropan-1-amine (ß-methylphenylethylamine, BMPEA)
• 3-Methylhexan-2-amine (1,2-dimethylpentylamine)
• 4-Fluoromethylphenidate
• 4-Methylhexan-2-amine (1,3-dimethylamylamine, 1,3 DMAA, methylhexaneamine)
• 4-Methylpentan-2-amine (1,3-dimethylbutylamine)
• 5-Methylhexan-2-amine (1,4-dimethylamylamine, 1,4-dimethylpentylamine, 1,4-DMAA)
• Benzfetamine
• Cathine**
• Cathinone and its analogues, e.g. mephedrone, methedrone, and ɑ - pyrrolidinovalerophenone
• Dimetamfetamine (dimethylamphetamine)
• Ephedrine*
• Epinephrine** (adrenaline)
• Etamivan
• Ethylphenidate
• Etilamfetamine
• Etilefrine
• Famprofazone
• Fenbutrazate
• Fencamfamin
• Heptaminol
• Hydroxyamfetamine (parahydroxyamphetamine)
• Isometheptene
• Levmetamfetamine
• Meclofenoxate
• Methylenedioxymethamphetamine
• Methylephedrine*
• Methylnaphthidate [(±)-methyl-2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate]
• Methylphenidate
• Midodrine
• Nikethamide
• Norfenefrine
• Octodrine (1,5-dimethylhexylamine)
• Octopamine
• Oxilofrine (methylsynephrine)
• Pemoline
• Pentetrazol
• Phenethylamine and its derivatives
• Phenmetrazine
• Phenpromethamine
• Propylhexedrine
• Pseudoephedrine***
• Selegiline
• Sibutramine
• Solriamfetol
• Strychnine
• Tenamfetamine (methylenedioxyamphetamine)
• Tesofensine
• Tuaminoheptane

and other substances with a similar chemical structure or similar biological effect(s).

Except:

• Clonidine, guanfacine
• Imidazoline derivatives for dermatological, nasal, ophthalmic or otic use (e.g. brimonidine, clonazoline, fenoxazoline, indanazoline, naphazoline, oxymetazoline, tetryzoline, tramazoline, xylometazoline) and those stimulants included in the 2026 Monitoring Program*

* Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol, and synephrine: These substances are included in the 2026 Monitoring Program and are not considered Prohibited Substances.
** Cathine (d-norpseudoephedrine) and its l-isomer: Prohibited when its concentration in urine is greater than 5 micrograms per millilitre.
*** Ephedrine and methylephedrine: Prohibited when the concentration of either in urine is greater than 10 micrograms per millilitre.
**** Epinephrine (adrenaline): Not prohibited in local administration, e.g. nasal, ophthalmologic, or co-administration with local
anaesthetic agents.
***** Pseudoephedrine: Prohibited when its concentration in urine is greater than 150 micrograms per millilitre.

S7. NARCOTICS

PROHIBITED IN-COMPETITION

All prohibited substances in this class are Specified Substances.

Substance of Abuse in this section: diamorphine (heroin)

The following narcotics, including all optical isomers, e.g. d- and l- where relevant, are prohibited.

• Buprenorphine
• Dextromoramide
• Diamorphine (heroin)
• Fentanyl and its derivatives
• Hydromorphone
• Methadone
• Morphine
• Nicomorphine
• Oxycodone
• Oxymorphone
• Pentazocine
• Pethidine
• Tramadol

S8. CANNABINOIDS

All prohibited substances in this class are Specified Substances.

Substance of Abuse in this section: tetrahydrocannabinol (THC)

All natural and synthetic cannabinoids are prohibited, e.g.
• In cannabis (hashish, marijuana) and cannabis products
• Natural and synthetic tetrahydrocannabinols (THCs)
• Synthetic cannabinoids that mimic the effects of THC

Except:

Cannabidiol

S9. GLUCOCORTICOIDS

All prohibited substances in this class are Specified Substances.

All glucocorticoids are prohibited when administered by any injectable, oral [including oromucosal (e.g. buccal, gingival, sublingual)] or rectal route.

Including but not limited to:

• Beclometasone
• Betamethasone
• Budesonide
• Ciclesonide
• Cortisone
• Deflazacort
• Dexamethasone
• Flunisolide
• Fluocortolone
• Fluticasone
• Hydrocortisone
• Methylprednisolone
• Mometasone
• Prednisolone
• Prednisone
• Triamcinolone acetonide

NOTE:

• Other routes of administration (including inhaled, and topical: dental-intracanal,
dermal, intranasal, ophthalmological, otic and perianal) are not prohibited when used within the manufacturer’s licensed doses and therapeutic indications.